Active	Status	Sponsor type	Region	Phase	Filter
8 Active 0 Inactive 8 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

8 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Kulkarni, Roshni
B-Natural, NCT02502409: Natural History Study of Factor IX Treatment and Complications	Active, not recruiting	N/A	550	US	Standard care with blood and urine sample collection	Skane University Hospital, Indiana Hemophilia &Thrombosis Center, Inc., Bioverativ Therapeutics Inc., Swedish Orphan Biovitrum	Factor IX Deficiency	06/19	12/21
NCT03853486: ATHN 9: Severe VWD Natural History Study	Active, not recruiting	N/A	108	US		American Thrombosis and Hemostasis Network, Takeda	Von Willebrand Diseases	12/24	01/25
PRESent-5, NCT05605678: Hemophilia Non-Interventional Study Prior to SerpinPC Intervention	Recruiting	N/A	200	Europe, Canada, US, RoW	No Intervention	ApcinteX Ltd, Centessa Pharmaceuticals plc	Hemophilia A, Hemophilia B	11/24	11/24
Jobe, Shawn
ATHN 16, NCT04647227: SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors	Recruiting	4	55	US	coagulation factor VIIa [recombinant]-jncw, SEVENFACT	American Thrombosis and Hemostasis Network, LFB USA, Inc.	Hemophilia A With Inhibitor, Hemophilia B With Inhibitor	11/24	06/25
NCT02932618 / 2016-001477-33: A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)	Recruiting	3	34	Europe, US, RoW	von Willebrand factor (Recombinant), VONVENDI, rVWF, BAX111, BAX 111, Antihemophilic Factor (Recombinant), ADVATE, Recombinant Factor VIII, rFVIII	Baxalta now part of Shire, Takeda Development Center Americas, Inc.	Von Willebrand Disease	01/25	01/25
NCT03853486: ATHN 9: Severe VWD Natural History Study	Active, not recruiting	N/A	108	US		American Thrombosis and Hemostasis Network, Takeda	Von Willebrand Diseases	12/24	01/25
Brown, Megan
ATHN 16, NCT04647227: SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors	Recruiting	4	55	US	coagulation factor VIIa [recombinant]-jncw, SEVENFACT	American Thrombosis and Hemostasis Network, LFB USA, Inc.	Hemophilia A With Inhibitor, Hemophilia B With Inhibitor	11/24	06/25
Burghardt, Anna
ATHN 16, NCT04647227: SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors	Recruiting	4	55	US	coagulation factor VIIa [recombinant]-jncw, SEVENFACT	American Thrombosis and Hemostasis Network, LFB USA, Inc.	Hemophilia A With Inhibitor, Hemophilia B With Inhibitor	11/24	06/25